Short answer
Not in any meaningful way. HRT is not FDA-approved for weight loss. A Cochrane review of randomized trials found no effect on body weight, either up or down. The Menopause Society says hormone therapy may help limit belly fat and weight gain during the menopause transition, but that the effect is small.
What happens to weight and fat in the transition
The Study of Women's Health Across the Nation (SWAN), a US study funded by the NIH, tracked body composition with DXA scans. At the start of the menopause transition, the rate of fat gain doubled and lean mass began to fall. Both changes continued until about 2 years after the final menstrual period, then leveled off.
Weight itself told a quieter story. It climbed steadily before menopause, did not speed up at the transition, and flattened afterward. The Menopause Society puts average midlife weight gain at 1.5 lb a year, with fat shifting toward the middle after menopause.
What the trials found on weight
A Cochrane review pooled 22 randomized trials. Women on estrogen alone gained 0.66 kg more than women not on HRT, and women on estrogen plus progestogen gained 0.47 kg less. Neither difference was statistically significant. The reviewers concluded that HRT does not cause extra weight gain beyond what normally happens at menopause.
That cuts both ways. The same evidence that clears HRT of causing weight gain also shows it does not produce weight loss. The review's search ran to August 1998, so newer formulations are not covered.
The WHI body composition data
A substudy of the Women's Health Initiative randomized 835 women, average age 63 and about 14 years past menopause, to estrogen plus progestin or placebo. After 3 years, the hormone group lost less lean soft tissue (0.04 kg versus 0.44 kg on placebo) and had less fat shift toward the upper body.
The authors were careful: the effect sizes were small, and whether these changes lead to real health benefits remains to be confirmed. This was also an older group, on average about 14 years past menopause.
What the label and the Menopause Society say
An FDA-approved estradiol patch label lists four uses: hot flashes, vaginal atrophy, low estrogen from ovarian failure or removal, and preventing postmenopausal osteoporosis. Weight loss is not one of them. The label lists weight increase among reports after approval, which cannot prove cause.
The Menopause Society's 2022 position statement names weight gain, bloating and fluid retention among the more common side effects. If weight is your main concern, raise it with your prescriber as a separate goal, and do not change a hormone prescription on your own.
Related questions
Does HRT make you gain weight?
Pooled trials say no extra gain beyond what menopause brings on its own. The Menopause Society still lists weight gain, bloating and fluid retention among the more common possible side effects.
Can HRT reduce belly fat?
Slightly, at most. In the WHI substudy, women on estrogen plus progestin had less fat shift to the upper body over 3 years, but the authors called the effect small.
Do patches and pills differ for weight?
The trials covered here do not answer that. The WHI substudy tested estrogen plus progestin against placebo, not one route against another.
Read next
Sources
- Norman et al., Cochrane Database of Systematic Reviews: Oestrogen and progestogen HRT for peri-menopausal and post-menopausal women: weight and body fat distribution (2000)
- Greendale et al., JCI Insight: Changes in body composition and weight during the menopause transition (SWAN, 2019)
- Chen et al., American Journal of Clinical Nutrition: Postmenopausal hormone therapy and body composition, a substudy of the WHI estrogen plus progestin trial (2005)
- The Menopause Society: The 2022 Hormone Therapy Position Statement of The North American Menopause Society (2022)
- DailyMed (NIH): Estradiol Transdermal System prescribing information (label version published 5 Mar 2026)
Published 2026-10-07 · Last checked 2026-10-07
Educational content, not medical advice. Made for the United States.